IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood.

TitleIL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood.
Publication TypeJournal Article
Year of Publication2014
AuthorsWang CQF, Suárez-Fariñas M, Nograles KE, Mimoso CA, Shrom D, Dow ER, Heffernan MP, Hoffman RW, Krueger JG
JournalJ Invest Dermatol
Volume134
Issue12
Pagination2990-2993
Date Published2014 Dec
ISSN1523-1747
KeywordsAntibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Cells, Cultured, Cytokines, Dose-Response Relationship, Drug, Humans, Infusions, Intravenous, Injections, Subcutaneous, Interleukin-17, Monocytes, Psoriasis, Receptors, Chemokine, Signal Transduction, Treatment Outcome
DOI10.1038/jid.2014.268
Alternate JournalJ. Invest. Dermatol.
PubMed ID24999591

Person Type: